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Abstract: Azaperone is a butyrophenone tranquilizer for swine. 
Food producing pigs are particularly sensitive to stress during 
handling and transport to the abattoir. In vivo, azaperone is partially 
metabolised to azaperol, a metabolite with pharmacological activity. 
The high and persistent concentrations of azaperone and azaperol in 
the injection site contra-indicates the use of azaperone using the 
intramuscular route for the transport of the food producing animals, 
pigs, to the slaughterhouse; the oral use could be an alternative to 
avoid residues at the injection site. The present study determined the 
tissue depletion of azaperone and its metabolite azaperol after oral 
administration of the formulation Stresnil®. Male pigs (30-45 kg of 
body weight) were treated with Stresnil® (single oral dose of 4 mg 
azaperone/kg body weight) and were sacrificed 6, 24 and 48 hours 
after the administration. Muscle, skin + fat, liver and kidney were 
collected from each animal. Azaperone and azaperol were assayed by 
HPLC after solid phase extraction. The concentrations of the 
azaperone plus azaperol in all analysed tissues did not exceed to the 
Maximum Residue Limit (MRL) established by the European Union 
(100 μg/kg in muscle, liver, kidney and skin plus fat) at any sampling 
time. As a consequence, from the results obtained in the present study, 
edible tissues of pigs treated orally with 4 mg/kg azaperone, 6 hours 
before to the sacrifice, might be acceptable to guarantee safety for the 
consumers. Nevertheless a withdrawal time of cero hours was 
estimated by linear regression analysis. 
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Resumen: Depleción tisular de azaperona y su metabolito 
azaperol tras administración oral de azaperona en cerdo. 
Azaperona es un tranquilizante de tipo butirofenona usado en ganado 
porcino. Los cerdos son particularmente sensibles al estrés durante el 
manejo y transporte al matadero. La azaperona es parcialmente 
metabolizada in vivo a azaperol, un metabolito con actividad 
farmacológica. Las concentraciones altas y persistentes de azaperona 
y azaperol en el lugar de inyección contraindican el uso de azaperona 
por vía intramuscular para el transporte de cerdos de producción de 
carne al matadero; el uso oral podría ser una alternativa para evitar 
residuos en el lugar de inyección. El presente estudio determinó la 
depleción en los tejidos de azaperona y su metabolito azaperol 
después de la administración oral de la formulación Stresnil®. 
Cerdos machos (30-45 kg de peso corporal) fueron tratados con 
Stresnil® (dosis oral única de 4 mg azaperona/kg de peso corporal) y 
se sacrificaron 6, 24 y 48 horas después de la administración. De cada 
animal se obtuvo músculo, piel + grasa, hígado y riñón. Azaperona y 
azaperol se analizaron por HPLC tras la extracción en fase sólida. Las 
concentraciones de azaperona más azaperol en todos los tejidos 
analizados no superaron el Límite Máximo de Residuos (LMR) 
establecidos por la Unión Europea (100 mg / kg en el músculo, el 
hígado, los riñones y la piel + grasa) en ningún momento del 
muestreo. Como consecuencia, según los resultados obtenidos en el 
presente estudio, los tejidos comestibles de los cerdos tratados por vía 
oral con 4 mg/kg de azaperona, 6 horas antes al sacrificio, podrían ser 
aceptables para garantizar la seguridad de los consumidores. Sin 
embargo, se estimó un tiempo de espera de cero horas por análisis de 
regresión lineal.
Palabras clave:  azaperona, azaperol,  cerdo, residuos, 
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Introduction 
Intensive livestock production increased meat production and 
reduced costs in industrialised countries. Swine represents nearly 
50% of the meat consumed in some European countries. Pigs are 
particularly sensitive to stress during handling and transport to the 
abattoir. This phenomenon leads to high mortality rates and poor-
quality meat qualified as "Pale Soft Exudative" (PSE) [1]. For this 
reason, the use of tranquillizers has become generalised since 1970s. 
Phenothiazine derivatives (acepromazine, chlorpromazine and 
propionylpromazine) were the first to appear on the market. 
Currently their use is banned in food production animals as veterinary 
medicinal products. 
Azaperone, the active principle of Stresnil®, a butyrophenone 
neuroleptic, developed for swine and widely used in pig production 
[2]. In veterinary medicine, azaperone is used in pigs for a wide 
variety of indications (anti-aggressiveness, obstetrics, stress, 
sedation and anaesthesia). Azaperone is partially metabolised to 
azaperol, a metabolite with some pharmacological activity [3,4]. 
Azaperone has been also used to reduce aggressive behavior in young 
pigs and has been claimed to increase food conversion efficiency in 
groups where previously unacquainted pigs were mixed together [5]. 
Azaperone acts by blocking dopamine receptors in the brain, and 
unlike the most antipsychotic neuroleptics, azaperone is a potent α-
receptor blocker at low dose, while dopamine receptor is blocked 
only at high doses. Azaperone is thought to depress the activity in the 
reticular activating system. This fact decreases the ability of the 
animal to respond to external signals making the animal relatively 
indifferent to its surroundings [6]. The clinical effects remain during 4 
to 8 hours [7]. Many boars are transported together to slaughterhouse 
and they often fight under these circumstances. This may result in 
unnecessary suffering and economic loss due to damaged carcasses. 
For this reason azaperone is widely used. 
Current industry standards and codes of practice have attempted to 
alleviate the problems associated with shipping cull boars for * e-mail: nmestorino@fcv.unlp.edu.ar 
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slaughter by requiring individual segregation, but welfare concerns 
remain. It has been well documented that the mixing of unfamiliar 
groups of pigs results in increased aggressive behavior and fighting 
among the animals in order to establish a new dominance hierarchy 
[8]. The most severe aggression normally occurs during the first 30 to 
90 min after the groups have been mixed [9], and although the overt 
aggressive acts are not seen commonly after the first 24 hours of 
mixing and only low levels of fighting can be observed up to 8 days 
after regrouping, sufficient stresses is presented causing a reduction 
in performance [10]. A study in Australia showed that mixing a 
relatively small number of boars during lairage induced fighting 
among the pigs, resulting in a high incidence of skin lesions and 
inferior pork quality [8]. 
During the pre-slaughter handling of pigs, unfamiliar groups of pigs 
will often be mixed together. Currently, in countries as Canada, the 
Health of Animals Regulations prohibits the transportation of groups 
of animals that are "incompatible by nature". These Regulations state 
that groups of bulls, de-tusked boars, rams and goat bucks, if mature, 
shall be segregated from all other animals during transport [11]. 
Although not specifically, this suggests that cull boars being 
transported in groups are to be detusked prior to mixing and if not, 
must be transported in individual compartments. 
Azaperone is thought to act on CNS to make animals indifferent to 
their surrounding environment [6-12]. Studies have shown that 
azaperone causes quantitative changes in pig behavior that could be 
interpreted as indicating an anxiolytic effect [13,14]. Azaperone have 
been also described as an effective sedative in small and medium-
sized antelope and deer species at dose range of 0.05–2.83 mg/kg 
body weight [15]. Azaperone used as a sedative at low doses has been 
found to reduce emotionality in sheep tested in an open field test [16] 
and to increase inter-individual distance and lower shade preference 
when given to sheep before testing in a novel environment [17]. 
Biotransformation of azaperone leads primarily to the production of 
its reduced metabolite azaperol (Fig. 1). Azaperone has 4–30 times 
the biological potency of azaperol [3]. Azaperol is the only metabolite 
with pharmacological activity. Residues of azaperone are evaluated 
as the sum of azaperone and azaperol because the activity of azaperol 
may be associated with its ready intercom version with azaperone. 
Although some evidence exists that azaperol is pharmacologically 
less effective than azaperone, for an adequate safety evaluation for 
the consumer, residues of azaperol are considered to be as harmful as 
those of azaperone [18]. The Committee for Veterinary Medicinal 
Products (CVMP) of the European Agency for the Evaluation of 
Medicinal Products (EMEA) recommends the marker residue as sum 
of azaperone and azaperol for establish the MRL. European Union 
Commission Regulation (EC) No 1958/98 [19] as an amendment to 
Council Regulation (EEC) No 2377/90 [20] classifies azaperone as a 
substance with MRL in the animal species porcine of 100 µg/kg in 
muscle, skin + fat, liver and kidney being the marker residue the sum 
of azaperone and azaperol [21]. 
The pharmacologically active compounds azaperone and azaperol 
deplete to undetectable levels within a few days after intramuscular 
administration in all edible tissues except injection site. The high and 
more persistent concentrations of azaperone and azaperol in the 
injection site might contra-indicate the use of azaperone for transport 
of pigs to the slaughterhouse, however due to the stress and 
aggressivity triggered by this situation it might be necessary its use. 
Taking into account the more persistence concentrations of azaperone 
and azaperol in the injection-site, the oral use could be a solution to 
avoid residues at the injection site of animals being transported. 
The objectives of this paper were to determine the residue depletion 
of azaperone and its metabolite, azaperol in edible tissues of pigs after 
single oral administration 
Materials and Methods 
Animals and Experimental Design 
Thirteen young, 3 months old Duroc Jersey pigs with a body weight 
between 30-45 kg, were treated with the formulation Stresnil® 
(Janssen Animal Health) at the recommended single oral dose of 4 mg 
azaperone/kg body weight (i.e., equivalent to 2 mL per 20 kg body 
weight). The Stresnil formulation was diluted in water and 
administered orally directly into the mouth by a syringe attached to a 
cannula. All the animals were housed in the experimental farm of the 
La Plata University and allowed to acclimatize for 7 days prior the 
study start. The animals were kept in individual pens with free access 
to water and food (a proprietary pig feed) in amounts adjusted to their 
body weight. The protocol followed the Guide for the Care and Use of 
Agricultural Animals in Agricultural Research and Teaching 
(Federation of Animal Science societies -FASS-). Five pigs were 
slaughtered by insensitization and exsanguinations at 6 hours after 
oral drug administration. Four pigs were sacrificed at 24 hours and 
another 4 pigs at 48 hours after the oral drug administration. Samples 
of 100 g of liver, kidney, muscle and skin + fat were obtained from 
each treated animal and stored in individual bags at -40°C until assay. 
Tissue samples from two untreated animals (control tissues) were 
also obtained to be used in the validation analytical method. 
Chemicals and Reagents 
The reagents used were HPLC-grade acetonitrile (Sigma Aldrich®), 
sodium chloride (J.T. Baker®), sulfuric acid (J.T. Baker®), acetic 
acid (J.T. Baker®), and anhydrous sodium acetate (J.T. Baker®). 
Azaperone and azaperole reference standards were supplied by 
Janssen Animal Health BVBA (Beerse, Belgium). Stock standard 
solutions (1 mg/mL) were prepared in acetonitrile. 
Analytical Method and Validation 
Azaperone and azaperol concentrations in tissues were measured 
using a HPLC technique. 
Extraction and clean-up procedure. The extraction was performed in 
an automatic solid-phase extraction system (Gilson Aspec XL, 
France) using Strata (C18, 100 mg, 1 mL, Phenomenex Torrance, CA, 
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Figure 1. Chemical structure of azaperone (AZA) and azaperol 
(AZOL) 
USA) cartridges. Tissues were homogenized with a grinder. One g of 
sample was weighed and 4 mL acetonitrile added under continuous 
mixing. The mixture was vortexed for 15 min, sonicated 2 min, 
centrifuged at 4000 G for 20 min. The supernatant was mixed with 8 
mL 10% NaCl and added to the cartridge, the cartridge was washed 
with 1 mL 10 mM sulphuric acid, then 2 mL air and eluted with 2 mL 
acidic acetonitrile (1 mL 50 mM sulphuric acid plus 100 mL 
acetonitrile). The eluate was placed in a tube and evaporated to 
dryness in a thermostatic bath at 70°C and under nitrogen flow. The 
dried extract was dissolved in 300 μL acetonitrile and 10 mM 
sulphuric acid (1:1). A 100 μL aliquot of this solution was injected 
into the HPLC system. The retention times of azaperone and azaperol, 
under the above-described conditions, were about 4.95 and 7.5 min., 
respectively (Figure 2). 
HPLC analysis. The chromatographic system consisted of an 
isocratic pump (Gilson Inc. 307), an automatic injector (Gilson Inc. 
234), a UV-VIS detector (Gilson Inc. 155) set at a wavelength of 240 
nm and Eppendorf CH-30 ColumnHeater (set at a 50ºC). The system 
is controlled through the Unipoint® Gilson system. An C18 column 
(Gemini 5 μm, 4.6 mm x 150 mm, 5 μm; Phenomenex, Torrance,CA, 
USA) was eluted with a mixture of acetonitrile : water 55:45 (with 
2,46 g/L anhydrous sodium acetate, pH adjusted to 6.5 with acetic 
acid) at a flow rate of 1.2 mL/min. Identification of the metabolites in 
pig tissues were made by comparison with the retention times of the 
reference standards. The analytical method was fully validated for the 
compounds azaperone and azaperol (linearity, recovery rate, 
accuracy, precision, trueness, quantification limit (LOQ), detection 
limit (LOD) and specificity). The precision of the extraction 
procedure and chromatography was evaluated by processing as 
replicates in six different  occasions, aliquots of pooled different 
tissue samples containing known amounts of azaperone and azaperol. 
Drug concentrations were determined from peak areas and the use of 
calibration curves obtained by running tissue samples from pigs not 
treated with Stresnil® (i.e. pigs control group) that were spiked with 
known concentrations of azaperone and azaperol. For tissue 
specimens as determined using the linear least squares regression 
procedure, a linear relationship existed in the calibration curve of 
azaperone and azaperol over the range of 0.03 to 0.5 μg/g for muscle, 
liver and kidney, which always yielded a correlation coefficient 
exceeding 0.9889 (range 0.9889 to 0.9999) (Figure 3). Overall mean 
recovery of azaperone and azaperol from was greater than 99% and 
89%, respectively. Within-day and day-to-day precision were < 
2.365% for azaperone and <10.18% for azaperol. The LOD was 
0.002 μg/g for azaperone and 0.003 μg/g for azaperol in muscle, liver, 
skin + fat and kidney. The LOQ was 0.010 μg/g for azaperone and 
azaperol with an accuracy of 89.54% with a CV of 12.72% in all 
tissues. The method was selective for those substances analyzed; no 
endogenous interference was observed on the HPLC chromatograms. 
Results and Discussion 
Many techniques are currently available for detecting the presence of 
azaperone residues. Immunological methods [23] allow efficient 
screening, but also positive results have been confirmed by physic-
chemical methods. Among the techniques that have been reported are 
thin-layer chromatography [24] and liquid chromatography 
extraction coupled with electrochemical detection [25] or 
fluorescence detection [26]. These methods require extensive clean-
up and do not allow sufficiently sensitive detection. In recent years 
several studies were performed with techniques of liquid 
chromatography with UV detection and liquid chromatography-
tandem mass spectrometry [27,28]. These techniques have the 
advantage of being very sensitive. For this reason we have validated a 
technique by HPLC with UV detection. The method described has 
good sensitivity and specificity, the limits of detection were low and 
the quantification was well below the MRL established by the 
EMEA. Validation parameters of the procedure for determining 
azaperone + azaperol residues in pig tissues were in accordance with 
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Figure 2. HPLC Chromatogram corresponding to an injection of 
muscle sample spiked with 200 ng/g of azaperone (AZA) and 
azaperol (AZOL) 
Figure 3. Representative calibration curves (A) for azaperone and 
(B) azaperol. The calibration curves were obtained by running muscle 
samples from control pigs that were spiked with known 
concentrations of azaperone and azaperol. 
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internationally required criteria [29]. 
In the present study, the concentrations of the residues in all tissues 
did not exceed 0.1 μg/g or 100 μg/kg at any sampling time. Six hours 
post-administration, levels of azaperone + azaperol were below their 
respective MRL in all tissues assayed. Our results are consistent with 
those of Delahaut et al. [28], although these authors administered a 
dose of 0.025 mg azaperone/kg body weight by the intramuscular 
route. In the study of Delahaut et al., the animals were slaughtered 2, 
6, or 24 hours after azaperone intramuscular injection. This timing 
was chosen to mimic field conditions as closely as possible (2 hours 
for a farm located near the abattoir, 6 hours for transport over a 
medium distance, and 24 hours for slaughter postponed to the next 
day). On the other hand, it was reported the plasma levels of 
azaperone after single intramuscular administration to pigs at a dose 
of 1 mg/kg body weight; plasma levels of azaperone reached a 
maximum concentration within 30 minutes and showed a biphasical 
depletion with half-lives between 60 minutes and 2.5 hours thereafter. 
Azaperone was rapidly distributed to tissues (with highest levels in 
kidney, liver and lung and lower levels in fat, brain and muscle) 
followed by a high rate of metabolism and elimination [21]. Excretion 
was with the urine (62 to 89% for single intramuscular doses of 4 and 
1 mg/kg bodyweight, respectively), mainly between 8 and 24 hours 
[21]. 
The results found in the present study on the tissue concentrations 
(μg/g) of azaperone + azaperol for pigs treated orally with Stresnil® 
(azaperone at a single oral dose of 4 mg/kg body weight) are shown in 
Table 1 and Figures 4-7. The mean ± SD azaperone + azaperol 
concentrations after oral administration of Stresnil® (single oral dose 
of 4 mg azaperone/kg body weight) to pigs in liver, muscle, kidney 
and skin+fat pigs tissues are presented in Figures 4 to 7. The sum of 
the concentrations of azaperone and azaperol is considered the most 
appropriate marker residue, due to both azaperone and its metabolite 
azaperol have pharmacological activity; on the basis of 
pharmacological activity, a pharmacological ADI of 0.8 μg/kg body 
weight (equivalent to 48 μg for a 60 kg person) has been set by the 
EMEA, formally European Medicines Agency (EMA). Besides, 
azaperol can be reconverted to azaperone. Although azaperol is less 
pharmacologically active than azaperone, as a worst case scenario in 
order to adequately protect the consumer, azaperol is considered as 
potent as azaperone. In our study, 6 hours after Stresnil® oral 
administration (4 mg azaperone/kg body weight), levels of azaperone 
plus azaperol were below the MRL (0.1 μg/g or 100 μg/kg) in all 
target tissues assayed. 
One of the major disadvantages that entail the administration of 
tranquilizers, in pigs for slaughter, by the intramuscular route is the 
high persistence of residual levels at the injection site. This problem 
could be absolutely solved by the oral administration. In this line, the 
present investigation is the first study that describes the residue tissue 
depletion of azaperone after oral administration to pigs. The sampling 
time chosen for this study is consistent with the peak concentrations 
observed for azaperone during this residue depletion study. 
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Table 1. Residues (μg/g) mean ± SD of azaperone (AZA) and azaperol 
(AZOL) in tissues of pigs slaughtered 6, 24 and 48 hours after PO 
administration of stresnil® (oral single dose of 4 mg azaperone/kg 
body weight) 
Figure 4. Mean liver concentrations of azaperone (AZA), azaperol 
(AZOL) and azaperone + azaperol (AZA + AZOL) in pigs 
slaughtered 6, 24 and 48 h after oral administration of Strenil® (single 
dose of 4 mg azaperone/kg body weight). 
Figure 5. Mean muscle concentrations of azaperone (AZA), azaperol 
(AZOL) and azaperone + azaperol (AZA + AZOL) in pigs 
slaughtered 6, 24 and 48 h after oral administration of Strenil® (single 
dose of 4 mg azaperone/kg body weight). 
Figure 6. Mean kidney concentrations of azaperone (AZA), azaperol 
(AZOL) and azaperone + azaperol (AZA + AZOL) in pigs 
slaughtered 6, 24 and 48 h after oral administration of Strenil® (single 
dose of 4 mg azaperone/kg body weight). 
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Numerous experimental designs and statistical approach are used to 
establish the  withdrawal time. The EMEA recommends the use of a 
linear regression technique as the choice method [30]. In our study, 
taking into account the MRLs in pigs and considering that the marker 
residue is the sum of azaperone and azaperol, the calculated 
withdrawal time was cero hours (Figure 8). Our results demonstrate 
that oral azaperone administration at the recommended dose not 
require withdrawal time respecting the MRL fixed for azaperone [31] 
and thus 0-day withdrawal time is proposed. Nevertheless, as 
precaution measure, we can conclude that, from the results obtained 
in the present experiment, edible tissues of pigs treated orally with 
azaperone at 4 mg/kg body weight, 6 hours previously to the sacrifice, 
should be a withdrawal time acceptable to guarantee safety of foods 
for the consumers. 
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